Accuray Incorporated is a medical devices business based in the US. Accuray Incorporated shares (ARAY) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.85 – a decrease of 1.07% over the previous week. Accuray Incorporated employs 987 staff and has a trailing 12-month revenue of around $446.6 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.85 |
|---|---|
| 52-week range | $1.40 - $3.05 |
| 50-day moving average | $1.92 |
| 200-day moving average | $2.14 |
| Wall St. target price | $6.13 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.16 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.89 from 2024-10-18
| 1 week (2024-10-15) | 1.07% |
|---|---|
| 1 month (2024-09-20) | 9.25% |
| 3 months (2024-07-22) | -3.08% |
| 6 months (2024-04-22) | -12.90% |
| 1 year (2023-10-20) | -31.27% |
|---|---|
| 2 years (2022-10-21) | -6.90% |
| 3 years (2021-10-22) | 4.37 |
| 5 years (2019-10-22) | 2.63 |
Valuing Accuray Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Accuray Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Accuray Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.08. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Accuray Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Accuray Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $9 million.
The EBITDA is a measure of a Accuray Incorporated's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $446.6 million |
|---|---|
| Operating margin TTM | 3.73% |
| Gross profit TTM | $154 million |
| Return on assets TTM | 0.41% |
| Return on equity TTM | -31.49% |
| Profit margin | -3.48% |
| Book value | $0.45 |
| Market Capitalization | $187.5 million |
TTM: trailing 12 months
We're not expecting Accuray Incorporated to pay a dividend over the next 12 months.
Over the last 12 months, Accuray Incorporated's shares have ranged in value from as little as $1.4 up to $3.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Accuray Incorporated's is 1.398. This would suggest that Accuray Incorporated's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin. .
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
What you need to know about investing in the leading indicator for the overall US stock market.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Read our beginner’s guide to trading options in the US.